Ademi LLP is investigating whether the proposed acquisition of Option Care Health (NASDAQ: OPCH) by CD&R and McKesson Corporation, provides fair value to Option Care Health’s public shareholders and whether Option Care Health’s Board adequately protected shareholder interests in negotiating and approving the transaction.
What Is Ademi LLP Investigating?
- The exchange ratio and whether it adequately reflects Option Care Health’s value and future prospects;
- Substantial change-of-control benefits available to Option Care Health insiders in connection with the transaction;
- Restrictions on competing transactions, including a significant termination penalty that may discourage another potential buyer from making a superior proposal; and
- The conduct of Option Care Health’s Board of Directors in negotiating and approving the transaction and whether the Board fulfilled its duties to public shareholders.